Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure

Recruiting now

Conditions studied: Critical Illness, Acute Kidney Injury, Sepsis, Systemic Inflammatory Response Syndrome

In brief

The use of extracorporeal blood purification therapies (EBPT) is becoming increasingly widespread worldwide in everyday clinical practice, particularly in the critical care setting. Nonetheless, most of the clinical trials aimed at exploring the effect of EBPT on patients' long-term outcomes have failed to demonstrate consistent results regarding 28 day- or hospital- mortality rates. The aim of this observational prospective registry is to evaluate if there is a cluster of critically ill patients that mostly benefits from extracorporeal blood purification therapies with different EBPTs.

Key facts

Study ID
NCT04033224
Run by
Careggi Hospital
People needed
1000
Starts
2019-07-16
Expected to finish
2025-09-30
Last updated by the study team
2025-02-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.